CRL
Charles River Laboratories International, Inc.
Stock
$290.19+3.36 (+1.17%)Close Oct 2, 2026
- Long-term debt, 2025
- $2.1B
- YoY, 2025
- −4.6%
- 5-year CAGR
- +2.1%
- 10-year CAGR
- +10.0%
Long-term debt
Long-term debt by fiscal year
| Period | Long-term debt | YoY |
|---|---|---|
| 2025 | $2.1B | −4.6% |
| 2024 | $2.2B | −15.4% |
| 2023 | $2.6B | −2.2% |
| 2022 | $2.7B | +1.7% |
| 2021 | $2.7B | +38.0% |
| 2020 | $1.9B | +4.3% |
| 2019 | $1.8B | +13.7% |
| 2018 | $1.6B | +49.0% |
| 2017 | $1.1B | −8.1% |
| 2016 | $1.2B | +44.7% |
| 2015 | $821M | +13.7% |
| 2014 | $722M | +12.5% |
| 2013 | $642M | +21.8% |
| 2012 | $527M | −25.0% |
| 2011 | $703M | +4.9% |
| 2010 | $670M | +46.5% |
| 2009 | $457M | — |